<DOC>
	<DOCNO>NCT00305500</DOCNO>
	<brief_summary>Objectives : To evaluate tolerability efficacy escitalopram treatment high dose 20-50 mg/d out-patients OCD Type study : Open label , prospective study . Number patient : 100 patient OCD Duration study : 18-weeks active treatment , 8-visits : Dose titration : One week 10mg Four week 20mg After 4 week 20mg treatment– partial/no response , accord YBOCS score clinical judgment , dose increase 50mg depend response , adverse event , patient preference judgment clinician 12 week follow high dose . Total 18 week follow-up .</brief_summary>
	<brief_title>Tolerability Efficacy High Dose Escitalopram Treatment Obsessive-Compulsive Disorder ( OCD )</brief_title>
	<detailed_description>Objectives : To evaluate tolerability efficacy escitalopram treatment dose high 20mg ( 20-50 mg/d ) patient OCD , non responsive partially responsive recommended dos . Type study : Open label , prospective study . Study location : Subjects recruit patient treat large clinic specialize mood disorder anxiety OCD . Backup site : ABARBANEL mental health center . Number patient : 100 patient OCD Duration study : 18-weeks active treatment , 8-visits : Dose titration : One week 10mg Four week 20mg After 4 week 20mg treatment– partial/no response , accord YBOCS score clinical judgment , dose increase 50mg depend response , adverse event , patient preference judgment clinician 12 week follow high dose . Total 18 week follow-up . Patients Inclusion Criteria : 1 . Men woman 18 year age 2 . DSM IV-TR criterion OCD 3 . OCD associate distress interference patient ’ life judge treat physician 4 . Yale-Brown Obsessive Compulsive Scale ( YBOCS ) total score ≥16 Exclusion Criteria : 1 . Other primary co-primary psychiatric disorder distressful patient OCD , evaluate investigator 2 . Patients history mania/bipolar disorder 3 . Patients use medication contraindicate use escitalopram 4 . Known contraindication use citalopram escitalopram . 5 . Unable understand give inform consent 6 . Prominent suicidal ideation ( 2 point MADRS “ suicidal thought ” item ) 7 . Alcohol substance dependence past 6 month 8 . Major physical illness 9. ) woman currently pregnant less 4 week childbirth Or b ) woman lactate Or c ) A woman childbearing potential use medically accept form contraception . 10 . Liver function abnormality 11 . EKG abnormality Study Design : An institutional review board acknowledge Israeli Ministry Health approve study . After complete description study patient , write informed consent obtain patient find eligible willing participate . The design open-labeled . The study last 18 week . Patients evaluate clinical assessment various questionnaire ( see “ rating scale ” section ) . Those diagnosed OCD fulfill inclusion exclusion criterion requirement start 4 week initial treatment escitalopram 20mg/d . After 4 week patient evaluate non-responders ( reduction Y-BOCS total score le 25 % ) continue treatment high escitalopram dose . Dose adjust accord clinical status clinician ’ judgment 50mg/d escitalopram . Patients evaluate periodically throughout study adverse reaction psychiatric status various rating scale well clinical evaluation investigator . Assessments : 1 . Yale-Brown Obsessive Compulsive Scale ( Y-BOCS ) Symptom Checklist 2 . Montgomery Åsberg Depression Rating Scale ( MADRS ) 3 . The Clinical Global Impression scale ( CGI ) consist two sub-scales : The Severity illness ( CGI-S ) Global improvement ( CGI-I ) . 4 . A checklist serotonergic specific adverse drug reaction + dizziness , bleed ecchymosis checklist 5 . Visual Analog Scale ( VAS ) assessment mental well-being every visit 6 . SDS ( Sheehan Disability Scale ) 7 . Recent concomitant medication every visit</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1 . Men woman 18 year age 2 . DSM IVTR criterion OCD 3 . OCD associate distress interference patient ’ life judge treat physician 4 . YaleBrown Obsessive Compulsive Scale ( YBOCS ) total score ≥ 16 1 . Other primary coprimary psychiatric disorder distressful patient OCD , evaluate investigator 2 . Patients history mania/bipolar disorder 3 . Patients use medication contraindicate use escitalopram 4 . Known contraindication use citalopram escitalopram . 5 . Unable understand give inform consent 6 . Prominent suicidal ideation ( 2 point MADRS “ suicidal thought ” item ) 7 . Alcohol substance dependence past 6 month 8 . Major physical illness 9 . Woman currently pregnant less 4 week childbirth , woman lactating , woman childbearing potential use medically accept form contraception . 10 . Liver function abnormality 11 . EKG abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2006</verification_date>
	<keyword>OCD</keyword>
	<keyword>Escitalopram</keyword>
</DOC>